European regulators approve Takeda’s acquisition of Shire after divestment 21-Nov-2018 By Maggie Lynch Takeda’s aim to acquire Shire for $62bn received a boost after regulators vote positively to approve the transaction following the divestment of Shire’s IBD drug.
AZ divests over $1bn worth of assets in one week 06-Nov-2018 By Maggie Lynch & Ben Hargreaves AstraZeneca sold two drugs to Grünenthal for $700m and, a week later, divested a further three drugs to Covis for $350m.
2018: The year that pharma got its house in order 29-Oct-2018 By Ben Hargreaves This year a number of companies made big moves to divest certain parts of their portfolios, but why has it been such a significant year for this?